comparemela.com

Latest Breaking News On - Physicians briefing - Page 4 : comparemela.com

IDSA: Piperacillin-Tazobactam, Cefepime Comparable for Suspected Infection

THURSDAY, Oct. 19, 2023 (HealthDay News) For hospitalized patients with suspected infection for whom a clinician initiated an order for antipseudomonal antibiotics within 12 hours of presentation to the

United-states
Boston
Massachusetts
Tennessee
Vanderbilt-university
American
Elana-gotkine
Edwardt-qian
Journal-of-the-american-medical-association
Vanderbilt-university-medical-center
Infectious-diseases-society-of-america-idweek
Healthday-news

Septoplasty Effective for Nasal Obstruction Linked to Deviated Septum

THURSDAY, Oct. 19, 2023 (HealthDay News) For adults with nasal obstruction associated with a deviated nasal septum, septoplasty is a more effective intervention than a defined medical management regimen,

United-kingdom
Newcastle-upon-tyne
Sean-carrie
Elana-gotkine
Healthday-news
Newcastle-upon-tyne-hospitals
Sino-nasal-outcome
Nasal-obstruction
Symptom-evaluation
Dcc
Fire

Rosuvastatin, Atorvastatin Have Comparable Efficacy for CAD

THURSDAY, Oct. 19, 2023 (HealthDay News) Rosuvastatin and atorvastatin have comparable efficacy for a composite outcome in adults with coronary artery disease, according to a study published online Oct.

South-korea
Seoul
Soult-ukpyolsi
Yong-joon-lee
Chong-kun-dang
Elana-gotkine
Yonsei-university-college-of-medicine
Healthday-news
Joon-lee
Yonsei-university-college
Sam-jin-pharmaceutical
Chong-kun-dang-pharmaceutical

Adult ADHD Linked to Increased Risk for Dementia

TUESDAY, Oct. 17, 2023 (HealthDay News) Adult attention-deficit/hyperactivity disorder (ADHD) is associated with an increased risk for dementia, according to a study published online Oct. 17 in JAMA Network

Israel
University-of-haifa
H-efa
Israeli
Elana-gotkine
Stephenz-levine
Healthday-news
Dcc
Fire
Tncen
Ealth-and-wellness
Ealthday

FDA Approves Velsipity for Moderate-to-Severe Ulcerative Colitis in Adults

TUESDAY, Oct. 17, 2023 (HealthDay News) The U.S. Food and Drug Administration approved Velsipity (etrasimod) for adults with moderately to severely active ulcerative colitis (UC).

Angela-hwang
Pfizer
Drug-administration
Lori-solomon
Healthday-news
Dcc
Fire
Tncen
Ealth-and-wellness
Ealthday
Physicians-briefing
Medicine

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.